Published in Vaccine Weekly, October 28th, 2009
"We're excited to have the opportunity to work with GeoVax on this program," said Jeffrey Bernard, Formatech's Director of Business Development. "The prevention, and eventual treatment, of HIV-1 certainly is a worthy cause....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-10-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.